Product Images Amlodipine Besylate
View Photos of Packaging, Labels & Appearance
- Amlodipine Besylate - afcca25d 0e19 4800 a55d 1714067a4400 01
- Figure 1 - Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo - afcca25d 0e19 4800 a55d 1714067a4400 02
- Figure 2 - Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups - afcca25d 0e19 4800 a55d 1714067a4400 03
- Label Image - lbl500905354
Product Label Images
The following 4 images provide visual information about the product associated with Amlodipine Besylate NDC 50090-5354 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo - afcca25d 0e19 4800 a55d 1714067a4400 02

Figure 2 - Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups - afcca25d 0e19 4800 a55d 1714067a4400 03

This description includes data points related to a clinical trial comparing the effects of Amlodipine versus a placebo on a group of 1318 patients. The text mentions information about the distribution of patients by gender, baseline sitting SBP levels, baseline vessel disease, vessels with stenosis, PCI-stent strata, and hazard ratio with a 95% confidence interval. The study appears to have subgroup analyses based on different criteria such as gender, vessel conditions, and PCI status.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.